American Healthcare REIT (NYSE:AHR) Director Scott Estes Sells 2,500 Shares of Stock

Key Points

• Director Scott Estes sold 2,500 shares at an average price of $59.32, totaling $148,300; he retained 18,989 shares after the transaction.
• American Healthcare REIT beat quarterly estimates, reporting EPS of $0.58 versus $0.56 expected and revenue of $742.15 million, up 29.5% year over year.
• Analysts broadly rate the stock a Buy, with a consensus price target of $63.31; shares traded at $59.36 on Tuesday.

American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) Director Scott Estes sold 2,500 shares of American Healthcare REIT stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $59.32, for a total transaction of $148,300.00. Following the completion of the transaction, the director directly owned 18,989 shares of the company's stock, valued at approximately $1,126,427.48. This represents a 11.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

American Healthcare REIT Stock Performance

AHR stock traded up $0.40 during trading on Tuesday, hitting $59.36. 3,438,194 shares of the company's stock traded hands, compared to its average volume of 3,010,128. The stock has a market capitalization of $12.94 billion, a price-to-earnings ratio of 121.14, a price-to-earnings-growth ratio of 1.38 and a beta of 0.78. American Healthcare REIT, Inc. has a 52 week low of $44.81 and a 52 week high of $59.53. The stock has a fifty day moving average price of $53.15 and a two-hundred day moving average price of $51.70. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.24.

American Healthcare REIT (NYSE:AHR - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.56 by $0.02. American Healthcare REIT had a net margin of 4.84% and a return on equity of 3.63%. The company had revenue of $742.15 million for the quarter, compared to the consensus estimate of $703.51 million. During the same period last year, the firm posted $0.44 EPS. The company's revenue for the quarter was up 29.5% on a year-over-year basis. As a group, equities analysts anticipate that American Healthcare REIT, Inc. will post 2.19 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 16th. Shareholders of record on Wednesday, September 30th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Wednesday, September 30th. American Healthcare REIT's payout ratio is presently 204.08%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AHR. Scotiabank raised their price target on American Healthcare REIT from $56.00 to $62.00 and gave the stock an "outperform" rating in a report on Wednesday, September 2nd. Citizens Jmp raised their price target on shares of American Healthcare REIT from $60.00 to $65.00 and gave the company a "market outperform" rating in a research note on Monday, July 27th. Citigroup lifted their price objective on shares of American Healthcare REIT from $65.00 to $67.00 and gave the company a "buy" rating in a research note on Tuesday. Weiss Ratings raised American Healthcare REIT from a "hold (c+)" rating to a "buy (b)" rating in a report on Monday. Finally, Zacks Research upgraded shares of American Healthcare REIT from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 2nd. Two investment analysts have rated the stock with a Strong Buy rating and thirteen have assigned a Buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $63.31.

Institutional Investors Weigh In On American Healthcare REIT

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Greenland Capital Management LP raised its position in shares of American Healthcare REIT by 94.7% during the second quarter. Greenland Capital Management LP now owns 185,000 shares of the company's stock worth $9,648,000 after purchasing an additional 90,000 shares during the period. WINTON GROUP Ltd purchased a new stake in shares of American Healthcare REIT during the second quarter valued at $1,377,000. Wellington Management Group LLP lifted its holdings in shares of American Healthcare REIT by 4.5% during the second quarter. Wellington Management Group LLP now owns 8,658,850 shares of the company's stock valued at $451,559,000 after purchasing an additional 375,063 shares during the last quarter. TD Waterhouse Canada Inc. boosted its position in shares of American Healthcare REIT by 25.6% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 291,978 shares of the company's stock valued at $14,807,000 after purchasing an additional 59,425 shares during the period. Finally, Pacer Advisors Inc. acquired a new position in shares of American Healthcare REIT in the 1st quarter valued at $1,377,000. Institutional investors and hedge funds own 16.68% of the company's stock.

About American Healthcare REIT

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.